Ribonucleotide reductase R2 component is a novel malignancy determinant that cooperates with activated oncogenes to determine transformation and malignant potential

被引:101
作者
Fan, HZ
Villegas, C
Wright, JA
机构
[1] MANITOBA INST CELL BIOL,WINNIPEG,MB R3E 0V9,CANADA
[2] UNIV MANITOBA,WINNIPEG,MB R3E 0V9,CANADA
关键词
D O I
10.1073/pnas.93.24.14036
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Ribonucleotide reductase is a highly regulated cell cycle-controlled activity that is essential for DNA synthesis and repair, A retroviral vector for the R2 component of mammalian ribonucleotide reductase, the rate-limiting protein for enzyme activity and DNA synthesis in proliferating cells, was constructed and introduced into mammalian cells, Expression of Myc epitope-tagged R2 protein in benign BALB/c 3T3 and NIH 3T3 cells leads to a greatly increased frequency of focus formation in cooperation with H-ras transformation, Four lines of H-ras-transformed mouse 10T1/2 fibroblasts showed increased growth efficiency in soft agar after infection with the recombinant R2 expression virus vector. Furthermore, cells with altered R2 expression also exhibited significantly reduced subcutaneous tumor latency and increased tumor growth rates in syngeneic mice, and showed markedly elevated metastatic potential in lung metastasis assays, The results indicate that altered R2 gene expression cooperates with ras in mechanisms of malignant progression. A major Ras pathway involves the Raf-1 protein, which is recruited to the plasma membrane for activation, We show that recombinant R2 expression leads to significant increases in membrane-associated Raf-1 protein and mitogen-activating protein kinase-2. activity suggesting a mechanism for the observed Ras/R2 synergism. In support of this finding, we observed that activated Rac-1, which operates parallel to Raf-1 and cooperates with Raf-1 in Ras activated pathways, also cooperates with R2 in cellular transformation, These studies demonstrate that the R2 protein can participate in other critical cellular functions in addition to ribonucleotide reduction, and that deregulated R2 is a novel tumor progressor determinant that cooperates in oncogene-mediated mechanisms, which control malignant potential.
引用
收藏
页码:14036 / 14040
页数:5
相关论文
共 39 条
[21]   IDENTIFICATION OF GENES EXPRESSED IN PREMALIGNANT BREAST DISEASE BY MICROSCOPY-DIRECTED CLONING [J].
JENSEN, RA ;
PAGE, DL ;
HOLT, JT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (20) :9257-9261
[22]  
KOONG AC, 1994, CANCER RES, V54, P5273
[23]   REQUIREMENT FOR RAS IN RAF ACTIVATION IS OVERCOME BY TARGETING RAF TO THE PLASMA-MEMBRANE [J].
LEEVERS, SJ ;
PATERSON, HF ;
MARSHALL, CJ .
NATURE, 1994, 369 (6479) :411-414
[24]   Oncogenic Raf-1 activates p70 S6 kinase via a mitogen-activated protein kinase-independent pathway [J].
Lenormand, P ;
McMahon, M ;
Pouyssegur, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (26) :15762-15768
[25]   ASSAY OF RIBONUCLEOTIDE REDUCTION IN NUCLEOTIDE-PERMEABLE HAMSTER CELLS [J].
LEWIS, WH ;
KUZIK, BA ;
WRIGHT, JA .
JOURNAL OF CELLULAR PHYSIOLOGY, 1978, 94 (03) :287-298
[26]  
MANN GJ, 1987, J CELL BIOL, V48, P5151
[27]  
MCCLARTY GA, 1990, J BIOL CHEM, V265, P7539
[28]  
MILLER AD, 1993, METHOD ENZYMOL, V217, P581
[29]   LINEAGE ANALYSIS IN THE VERTEBRATE NERVOUS-SYSTEM BY RETROVIRUS-MEDIATED GENE-TRANSFER [J].
PRICE, J ;
TURNER, D ;
CEPKO, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (01) :156-160
[30]   AN ESSENTIAL ROLE FOR RAC IN RAS TRANSFORMATION [J].
QIU, RG ;
CHEN, J ;
KIRN, D ;
MCCORMICK, F ;
SYMONS, M .
NATURE, 1995, 374 (6521) :457-459